ICA is extremely antioxidative, which can be potentially used in the treatment of AD disorders through inhibiting excessive oxidation, scavenging free radicals, and repairing mitochondrial DNA damage, possibly via the HIF-1A, BNIP3, PINK1, and Parkin pathways. Here, BNIP3 is linked to Alzheimer disease.